Armistice Capital’s Dogwood Therapeutics DWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.99M Sell
2,958,171
-174,315
-6% -$314K 0.05% 129
2026
Q2
$5.04M Sell
3,132,486
-147,514
-4% -$244K 0.06% 133
2026
Q1
$6.92M Buy
+3,280,000
New +$9.7M 0.12% 108

Other funds holding DWTX

Armistice Capital's DWTX Position: Q3 2026 in Review

Armistice Capital reduced its Dogwood Therapeutics (DWTX) stake by 5.6% in Q3 2026, selling an estimated $314K and leaving 2,958,171 shares worth $3.99M. The position accounts for 0.05% of the portfolio, ranked #129.

Armistice Capital first reported a position in DWTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.92M in Q1 2026. 22 funds tracked by Wall St. Rank hold DWTX as of Q3 2026.

  • Armistice Capital held 2,958,171 shares of Dogwood Therapeutics worth $3.99M as of Q3 2026.
  • Armistice Capital sold 174,315 Dogwood Therapeutics shares in Q3 2026, an estimated $314K.
  • Dogwood Therapeutics made up 0.05% of Armistice Capital's portfolio in Q3 2026, its #129 holding.
  • Armistice Capital first reported a position in Dogwood Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Armistice Capital's Dogwood Therapeutics position peaked at $6.92M in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.